Corient Private Wealth’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.67M Sell
160,247
-44,046
-22% -$1.77M 0.01% 788
2026
Q1
$7.4M Buy
204,293
+38,302
+23% +$1.47M 0.01% 725
2025
Q4
$6.39M Buy
165,991
+46,735
+39% +$1.76M 0.01% 691
2025
Q3
$4.32M Buy
119,256
+50,464
+73% +$1.76M 0.01% 759
2025
Q2
$2.36M Buy
68,792
+46,095
+203% +$1.46M ﹤0.01% 967
2025
Q1
$710K Buy
+22,697
New +$740K ﹤0.01% 1430

Other funds holding QLTY

Corient Private Wealth's QLTY Position: Q2 2026 in Review

Corient Private Wealth reduced its GMO US Quality ETF (QLTY) stake by 22% in Q2 2026, selling an estimated $1.77M and leaving 160,247 shares worth $6.67M. The position accounts for 0.01% of the portfolio, ranked #788.

Corient Private Wealth first reported a position in QLTY in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.4M in Q1 2026. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Corient Private Wealth held 160,247 shares of GMO US Quality ETF worth $6.67M as of Q2 2026.
  • Corient Private Wealth sold 44,046 GMO US Quality ETF shares in Q2 2026, an estimated $1.77M.
  • GMO US Quality ETF made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #788 holding.
  • Corient Private Wealth first reported a position in GMO US Quality ETF in Q1 2025 and has held it in 6 quarters since.
  • Corient Private Wealth's GMO US Quality ETF position peaked at $7.4M in Q1 2026.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.